34.35
Liquidia Corp (LQDA) 最新ニュース
LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label - Zacks Investment Research
Liquidia CBO Jason Adair sells $207,932 in shares after vesting - Investing.com
Liquidia Corp general counsel Schundler sells $389,948 of stock - Investing.com
Liquidia CCO Scott Moomaw sells $252,418 in company stock By Investing.com - Investing.com India
To cover stock-award taxes, Liquidia (LQDA) general counsel sells 13,692 shares at $28.48 each. - Stock Titan
Scott Moomaw Disposes 8,863 Shares of Liquidia Corp (LQDA) Following PSU Vesting on October 12, 2026 - Kalkine Media
Liquidia Corp's Rajeev Saggar Converts PSUs and Sells 9,218 Shares on October 12, 2026 - Kalkine Media
Liquidia Corp CBO Jason Adair Sells 7,301 Shares at $28.48 Following RSU and PSU Vesting in October 2026 - Kalkine Media
To cover stock-award taxes, Liquidia (LQDA) CFO and COO Kaseta sold 18,938 shares at $28.48 each. - Stock Titan
A tax-related sale at Liquidia (LQDA) totals 1,101 shares at $28.48 each. - Stock Titan
To cover stock-award taxes, Liquidia (LQDA) CEO Roger Jeffs sold 32,744 shares. - Stock Titan
To cover award taxes, Dana Boyle sells 5,892 Liquidia (LQDA) shares at $28.48 each. - Stock Titan
Stephen M. Bloch Sells 235,477 Liquidia Shares via Canaan VIII L.P. at $27.13 Average Price - Kalkine Media
Liquidia director Stephen Bloch sells $6.39m in shares - Investing.com
LIQUIDIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback - Zacks Investment Research
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% - Zacks Investment Research
Liquidia Corporation (LQDA) Stock Price & News - Syfe
Option exercises and share sales by Liquidia (NASDAQ: LQDA) director - Stock Titan
Liquidia (NASDAQ:LQDA) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
Director at Liquidia (NASDAQ: LQDA) plans $619K stock sale - Stock Titan
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now? - Yahoo Finance
Liquidia Corporation $LQDA Holdings Decreased by Opaleye Management Inc. - MarketBeat
Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio? - Yahoo Finance
What Could Put Liquidia (NASDAQ:LQDA) On A New Path? - Kalkine Media
LQDA - Finviz
LQDA - Finviz
LIQUIDIA CORP (NASDAQ:LQDA) Fits the Affordable Growth Screen - ChartMill
Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com India
Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com
Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com UK
Wellington Management Group LLP Sells 22,925 Shares of Liquidia Corporation $LQDA - MarketBeat
Liquidia Corp Stock Intrinsic Values - GuruFocus
Does FDA Fast Track For YUTREPIA In SSc Raynaud’s Change The Bull Case For Liquidia (LQDA)? - Yahoo Finance
Is Liquidia (LQDA) Still Undervalued As Fast Track News Tests Its Valuation? - Yahoo Finance
Liquidia (LQDA) Stock Looks Stretched On Earnings But Reasonable On Broader Checks - Yahoo Finance
Liquidia Corp CHRO Sarah Krepp Sells 274 Shares Under Pre-Set 10b5-1 Trading Plan - kalkinemedia.com
Liquidia Corp (NASDAQ: LQDA) Secures FDA Fast Track for YUTREPIA Targeting Raynaud’s Phenomenon in Up to 90% of Systemic Sclerosis Patients - Kalkine Media
How Does Liquidia Corporation's (NASDAQ:LQDA) PRINT Platform Actually Work? - Kalkine Media
Why Is Liquidia Stock Gaining Thursday?Liquidia (NASDAQ:LQDA) - Benzinga
Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations - Yahoo Finance
LQDA Looks 75.0% Undervalued on GF Value™ - GuruFocus
Liquidia’s YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud’s Phenomenon - Quiver Quantitative
Liquidia Gets FDA Fast Track for YUTREPIA Raynaud's | LQDA Stock News - Stock Titan
Liquidia Corporation $LQDA Shares Sold by Pale Fire Capital SE - MarketBeat
Liquidia Corporation (NASDAQ:LQDA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Liquidia Corp (LQDA) Shares Surge 4.1% -- What GF Score of 70 Te - GuruFocus
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress - finance.yahoo.com
Two lung-disease studies will be presented in Barcelona - Stock Titan
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference - The Manila Times
大文字化:
|
ボリューム (24 時間):